Similar plasma levels of ANGPTL4, sgp130, AFP, and HGF following only one to two fractions of SBRT were detected in HCC patients with or without liver toxicity at 3 months post SBRT. This evidence concerns the gene ANGPTL4 and hepatocellular carcinoma.